Drugs n Stuff 324 Eli Lilly’s NEW Strategy to Shut Down Peptide Sites + Steroid Q&A

Drugs n Stuff 324 Eli Lilly’s NEW Strategy to Shut Down Peptide Sites + Steroid Q&A

August 24, 2026 · 58 min

About this episode

The episode discusses Eli Lilly's legal actions against peptide companies and answers various steroid-related questions.

Eli Lilly is escalating its fight against companies selling unapproved retatrutide — and this time, the lawsuits could have implications far beyond GLP-1s. Dave Crosland and Scott McNally break down what makes these lawsuits different and what they could mean for research chemical and peptide companies serving the bodybuilding world. Then we get into your questions on Dianabol and estrogen testing, Raloxifene vs. Tamoxifen, cycling with an enlarged prostate, insulin protocols, long-term low-dose Anavar, micro dosing Tren, Masteron and vision issues, and more. 0:00 Will Lilly & Retatrutide Change the Research Chem Market? 0:45 Support the Show 1:25 What the Eli Lilly Lawsuits Could Mean for Bodybuilding 7:45 Lilly Targets Shipping, Social Media & Payment Processing 10:00 Social Media Crackdowns on Steroid & Gear Talk 13:00 Craziest Pre-Workouts Ever 16:50 Does Dianabol Estrogen Show Up on a Standard E2 Test? 18:30 Raloxifene vs. Tamoxifen 20:00 Steroid Cycles With an Enlarged Prostate 24:00 Insulin Protocols: Dave vs. Scott 44:20 Vigorous Steve’s Long-Term 5 mg Anavar Experiment 47:40 British Slang 52:00 Can 15–25 mg of Tren Per Week Do Anything? 53:45 Masteron & Vision Issues UK…

Sponsors

TRUE NUTRITION

More episodes of Think BIG Bodybuilding

Explore listener stats, chart rankings, contacts and more on the Think BIG Bodybuilding podcast page.